The Board of Directors of Glenmark Pharmaceuticals is scheduled to meet on September 26, 2025, to consider and approve the payment of an interim dividend. If declared, the record date for determining shareholders eligible for the dividend will be Tuesday, September 30, 2025. The company has also announced a trading window closure for designated persons regarding trading in the company’s equity shares.
Board Meeting for Interim Dividend
Glenmark Pharmaceuticals has announced a meeting of its Board of Directors to be held on Friday, September 26, 2025. The primary agenda is to consider and approve the payment of an interim dividend on the company’s equity shares for the financial year 2025-26.
Record Date Announcement
The company has specified that if the interim dividend is declared, the record date for determining shareholders who are eligible for the dividend payout will be Tuesday, September 30, 2025.
Trading Window Closure
Glenmark has also informed that, in compliance with regulations regarding insider trading, the trading window for designated persons has been closed. This restriction impacts trading in the company’s equity shares, and the window will remain closed until Sunday, September 28, 2025. This closure is to ensure compliance during the period of sensitive financial decisions.
Source: BSE
